University of Virginia
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
Bathing Babies and Allergy
- Conditions
- AllergyAtopic Dermatitis
- First Posted Date
- 2017-02-13
- Last Posted Date
- 2017-02-13
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 144
- Registration Number
- NCT03050658
- Locations
- 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States
Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery
Not Applicable
Completed
- Conditions
- Method of Tubal Ligation at the Time of Cesarean Section
- Interventions
- Procedure: SalpingectomyProcedure: Tubal ligation
- First Posted Date
- 2017-01-23
- Last Posted Date
- 2018-04-10
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 44
- Registration Number
- NCT03028623
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Effectiveness of Point-of-use Water Treatment Technologies to Prevent Stunting Among Children in South Africa
Not Applicable
- Conditions
- Diarrhoea;Infectious;PresumedDiarrhea TropicalEnvironmental ExposureDiarrhea, InfantileEnteropathyMalnutrition, Child
- Interventions
- Device: Safe-storage water containerDevice: Silver-impregnated ceramic tabletDevice: Silver-impregnated ceramic water filter
- First Posted Date
- 2017-01-06
- Last Posted Date
- 2018-05-14
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 415
- Registration Number
- NCT03012048
- Locations
- 🇿🇦
University of Venda, Thohoyandou, Limpopo, South Africa
Clinical Importance of Glucose Regulation in Relapsing MS
- Conditions
- Relapsing Remitting Multiple SclerosisClinically Isolated Syndrome
- First Posted Date
- 2016-12-28
- Last Posted Date
- 2018-11-07
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 160
- Registration Number
- NCT03004079
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics
Phase 2
Active, not recruiting
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 95
- Registration Number
- NCT03002389
- Locations
- 🇺🇸
Roselove NUNOO-ASARE, Keswick, Virginia, United States
Assessing Deformable Image Registration in the Lung Using Hyperpolarized-gas MRI
Phase 1
- Conditions
- Healthy Volunteers
- Interventions
- Drug: Hyperpolarized He3
- First Posted Date
- 2016-12-16
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 24
- Registration Number
- NCT02995590
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Midodrine in the Recovery Phase of Septic Shock
- First Posted Date
- 2016-12-13
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- University of Virginia
- Registration Number
- NCT02990546
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
The International Diabetes Closed Loop (iDCL) Trial: Protocol 1
Not Applicable
Completed
- Conditions
- Type1 Diabetes Mellitus
- Interventions
- Other: Sensor Augmented TherapyDevice: Artificial Pancreas
- First Posted Date
- 2016-12-07
- Last Posted Date
- 2022-12-05
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 127
- Registration Number
- NCT02985866
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Stanford University, Stanford, California, United States
🇺🇸William Sansum Diabetes Center, Santa Barbara, California, United States
A Trial of Alirocumab and Plaque Regression in Peripheral Arterial Disease
Phase 4
Completed
- Conditions
- Peripheral Arterial Disease
- Interventions
- Drug: Matching placeboDrug: Alirocumab
- First Posted Date
- 2016-11-08
- Last Posted Date
- 2023-05-10
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 40
- Registration Number
- NCT02959047
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸University of Virginia Health System, Charlottesville, Virginia, United States
Evaluating and Improving Functional Driving Vision of Patients With Astigmatism: Phase 3
Not Applicable
Completed
- Conditions
- Astigmatism
- Interventions
- Device: Placebo LensesDevice: Spherical LensesDevice: Toric Lenses
- First Posted Date
- 2016-11-01
- Last Posted Date
- 2021-10-06
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 51
- Registration Number
- NCT02950545
- Locations
- 🇺🇸
University of Virginia Driving Safety Laboratory, Charlottesville, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath